Tumor Grading

Tumor grading is fairly uncommon in lymphoma, although it is still sometimes used in the diagnosis of follicular lymphoma.

When a pathologist examines cancerous tissue from a biopsy under a microscope, he or she is looking for differences in microscopic appearance between healthy cells from that tissue and tumor cells from that tissue, and how they both fit in with the surrounding tissue structure. They want to see how the tumor cells compare to healthy cells in their appearance.

The grade of the tumor is determined by how different cancer cells look when compared to normal or healthy cells.

"Well-Differentiated"

If the tumor cells look fairly similar to healthy cells, the pathologist says the tumor is "well-differentiated." A well-differentiated tumor generally means that the cancer is not aggressive, or indolent.

As an indicator of aggressiveness, a well-differentiated tumor would be a low grade tumor, or grade one (G1).

The next rung on the ladder is a moderately differentiated tumor, which would also be a low-grade tumor but would be tagged as grade two (G2).

"Poorly Differentiated"

On the other hand, if the tumor cells look very different than the healthy cells, he or she says that the tumor is "poorly differentiated."

The less that the cancer cells seem to fit in with the existing tissue, the greater the ability of the cancer to spread. Grade three (G3) and grade four (G4) tumors are high grade tumors, either poorly differentiated, or worse, undifferentiated.

Grade vs. Stage

Grading is not the same thing as staging. A grade measures 'differentiation' and tells you about the relative aggressiveness of the cancer. The stage measures how much or how little the cancer has spread from the site of origin. A person could be diagnosed with a grade two non-Hodgkin's follicular lymphoma, stage III, or a grade three MALT lymphoma, stage II.

It is important to remember that specialists in some subtypes of cancer use their own established grading systems, such as the Nottingham system used in grading breast cancer, that do not apply to lymphomas.

Sources

Lymphoma Research Foundation
American Joint Committee on Cancer
National Cancer Institute

More Articles

More Articles

Secondary cancers are cancers that develop as a result of chemotherapy and/or...

Small lymphocytic lymphoma (SLL), is a type of non-Hodgkin lymphoma characterized by an excess of white blood cells in the...

Lymphoplasmacytic Lymphoma (LPL) is an indolent (slow growing) cancer that affects plasma cells. A plasma cell...

Lymphomas can arise from most any lymphatic tissue (lymph nodes, spleen, thymus, mucosa associated lymphoid...

Treatment for Non-Hodgkin’s Lymphomas (NHL) differs from patient to patient. The regimen used depends on the type of...

Over the years, various classification systems have been used to differentiate lymphoma types including the Rappaport Classification (used until...

Advances in the treatment of Hodgkin's lymphoma have resulted in remarkable survival rates, even for...

The question of what the difference is between leukemia and lymphoma is a commonly asked question. We should start by saying that emerging...

Lymphoma is a cancer of the lymphatic system, causing B-cell or...

As one of two primary categories of lymphatic cancer, Hodgkin's lymphoma (HL) attacks the patient's white...

The diagnosis of a low grade B cell lymphoma is both a specific and a non-specific diagnosis that contains the following components:

What...

Hearing about lymphoma recurrence is about the least-welcome news a patient can hear. But what exactly does it mean?

To begin, lymphoma...

BEAM chemotherapy is an acronym representing a small family of combination chemotherapy regimens that are used chiefly as salvage regimens in the...

This entry looks at a non-Hodgkin's lymphoma called true histiocytic lymphoma (THL), also referred to as diffuse histiocytic lymphoma, and...

The term 'metastatic lymphoma' does not refer to a diagnosis. Unlike many of the subtypes of lymphoma we have...